Search Results for: Siemens

Imaging Roundtable: CT

The CT systems market was valued at $4.9 billion last year, and there are no signs of it slowing down, according to a recent report from Kalorama Information. Contributing to the modality’s demand are an increasing number of clinical applications, an aging population, and the rising incidence of chronic disease. 24×7 reached out to a panel of experts to discuss key trends on their radar. Don’t miss out.

Read More

Siemens, Biogen to Jointly Develop MRI Tools for Multiple Sclerosis

Siemens Healthineers and biotechnology company Biogen have inked a deal to jointly develop MRI applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Officials for Siemens say this partnership will enable the development of new measurement tools to better understand and combat MS.

Read More

TEE Transducer Testing: More Than Just Compliance

Just over a year ago, a rule from the Intersocietal Accreditation Commission made it a requirement for hospitals to clean and perform electrical leakage tests on all transesophageal echocardiography (TEE) transducers between each procedure, in order to receive accreditation from the body. In this article, 24×7 associate editor Elaine Sanchez Wilson explains why TEE transducer testing involves more than just compliance, however.

Read More

Siemens Adds 1,000 Imaging Courses to Learning Platform

Siemens Healthineers has expanded its online learning platform PEPconnect to include approximately 1,000 new learning modules for medical imaging customers. Effective immediately, users can use PEPconnect to access training courses on Siemens Healthineers systems for imaging and minimally invasive therapy in seven different languages.

Read More

The Great Wait: Will the FDA Increase Service Regulations or Not?

Since March 2015, the FDA has been collecting information and receiving factual and anecdotal comments concerning whether there is a public health and safety issue that warrants increased regulation and oversight of medical device companies and individuals. This issue culminated in October’s two-day workshop of presentations to the FDA, which biomedical expert Patrick Lynch details in the latest installment of The LynchPin.

Read More